Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eeles

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Human Reproduction (Oxford, England)|January 8, 2013
Reproductive decision-making in young female carriers of a BRCA mutationL S Donnelly, M Watson, C Moynihan, et al.
Familial Cancer|May 18, 2007
Delivery of cancer genetics services: The Royal Marsden telephone clinic modelS Shanley, K Myhill, R Doherty, et al.
British Journal of Cancer|January 26, 2006
Feasibility of familial PSA screening: psychosocial issues and screening adherenceJ Sweetman, M Watson, A Norman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 20, 2007
AIDIT and IMPACT: building research collaborations in targeted prostate cancer screeningR Doherty, J Lubinski, E Manguoglu, et al.
Hereditary Cancer in Clinical Practice|September 3, 2009
Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directionsR Doherty, J Lubinski, E Manguoglu, et al.
British Journal of Cancer|July 2, 2025
Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriersR L Flaherty, M Falcinelli, A R Hesketh, et al.
British Journal of Cancer|January 26, 2006
The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial riskJ Melia, D Dearnaley, S Moss, et al.
British Journal of Cancer|April 7, 2011
Polygenic susceptibility to prostate and breast cancer: implications for personalised screeningN Pashayan, S W Duffy, S Chowdhury, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2001
A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?C Nutting, R S Camplejohn, R Gilchrist, et al.
British Journal of Cancer|July 25, 2013
Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-upA Creak, E Hall, A Horwich, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Human Reproduction (Oxford, England)|January 8, 2013
Reproductive decision-making in young female carriers of a BRCA mutationL S Donnelly, M Watson, C Moynihan, et al.
Familial Cancer|May 18, 2007
Delivery of cancer genetics services: The Royal Marsden telephone clinic modelS Shanley, K Myhill, R Doherty, et al.
British Journal of Cancer|January 26, 2006
Feasibility of familial PSA screening: psychosocial issues and screening adherenceJ Sweetman, M Watson, A Norman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 20, 2007
AIDIT and IMPACT: building research collaborations in targeted prostate cancer screeningR Doherty, J Lubinski, E Manguoglu, et al.
Hereditary Cancer in Clinical Practice|September 3, 2009
Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directionsR Doherty, J Lubinski, E Manguoglu, et al.
British Journal of Cancer|July 2, 2025
Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriersR L Flaherty, M Falcinelli, A R Hesketh, et al.
British Journal of Cancer|January 26, 2006
The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial riskJ Melia, D Dearnaley, S Moss, et al.
British Journal of Cancer|April 7, 2011
Polygenic susceptibility to prostate and breast cancer: implications for personalised screeningN Pashayan, S W Duffy, S Chowdhury, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2001
A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?C Nutting, R S Camplejohn, R Gilchrist, et al.
British Journal of Cancer|July 25, 2013
Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-upA Creak, E Hall, A Horwich, et al.
Pageof 11